New Neuropsychopharmacology Data Have Been Reported by Researchers at Nagoya University Graduate School of Medicine (Distinct Effects of Nonselective Rho-Kinase Inhibitor Fasudil and Selective Rho-Kinase 2 Inhibitor KD025 on Serotonin and...).

This article focuses on research from Nagoya University Graduate School of Medicine in Aichi, Japan, investigating the roles of Rho-kinases 1 and 2 in regulating serotonin and dopamine release in the nucleus accumbens (NAc) of mice. Using in vivo microdialysis, the study examined the effects of fasudil, a nonselective Rho-kinase inhibitor, and KD025, a selective Rho-kinase 2 inhibitor, finding that fasudil increased basal serotonin levels and suppressed depolarization-induced release of both serotonin and dopamine, while KD025 selectively suppressed serotonin release. The findings suggest distinct but significant roles for Rho-kinases 1 and 2 in neurotransmitter regulation relevant to psychiatric conditions such as schizophrenia. This research was supported by Japanese scientific agencies and contributes to understanding the molecular mechanisms underlying neurotransmitter release in the central nervous system. [Extracted from the article]